未登录

S

Shuaijun Ma

Fourth Military Medical University

H指数:11

被引数:380

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeted Expansion of Treg Cells to Induce Immune Tolerance after Kidney Transplantation

肾脏移植后通过靶向扩增Treg细胞诱导免疫耐受

Advanced Science

IF14.1

2025-10-240

OAAI

Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-01-070

OAAI

The impact of integrating PRIMARY score or SUVmax with MRI-based risk models for the detection of clinically significant prostate cancer

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2024-09-120

PRE

Avoiding unnecessary biopsy: the combination of PRIMARY score with prostate-specific antigen density for prostate biopsy decision

PROSTATE CANCER AND PROSTATIC DISEASES

IF5.8

2023-12-306

PRE

The PRIMARY Score

主要得分

CLINICAL NUCLEAR MEDICINE

IF9.6

2023-11-293

OAAI

A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2023-08-314

OA

NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling

IF3.4

2023-03-2819

OAAI

Lactobacillus johnsonii 6084 alleviated sepsis-induced organ injury by modulating gut microbiota

约氏乳杆菌通过调节肠道菌群6084减轻脓毒症引起的器官损伤

FOOD SCIENCE & NUTRITION

IF3.8

2022-07-226

OA

The first competing risk survival nomogram in patients with papillary renal cell carcinoma

SCIENTIFIC REPORTS

IF3.9

2021-06-047

OAAI

The Establishment of New Thresholds for PLND-Validated Clinical Nomograms to Predict Non-Regional Lymph Node Metastases: Using 68Ga-PSMA PET/CT as References

FRONTIERS IN ONCOLOGY

IF3.3

2021-04-156

OAAI

Down-regulation of SLC25A20 promotes hepatocellular carcinoma growth and metastasis through suppression of fatty-acid oxidation

SLC25A20的下调通过抑制脂肪酸氧化促进肝细胞癌的生长和转移

CELL DEATH & DISEASE

IF9.6

2021-04-0619

OAAI

Establishment and prospective validation of an SUVmax cutoff value to discriminate clinically significant prostate cancer from benign prostate diseases in patients with suspected prostate cancer by 68Ga-PSMA PET/CT: a real-world study

IF13.3

2021-01-0140

OAAI

Comparison of 68Ga-PSMA-617 PET/CT with mpMRI for the detection of PCa in patients with a PSA level of 4-20 ng/ml before the initial biopsy

SCIENTIFIC REPORTS

IF3.9

2020-07-0332

OAAI